Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001140361-14-022182
Filing Date
2014-05-19
Accepted
2014-05-19 16:52:55
Documents
1
Effectiveness Date
2014-05-19
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9141
  Complete submission text file 0001140361-14-022182.txt   10175
Mailing Address 260 EAST GRAND AVENUE, 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVENUE, 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 635-5500
ALIOS BIOPHARMA INC (Filer) CIK: 0001380990 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: D | Act: 33 | File No.: 021-217630 | Film No.: 14855207